• 1. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan
• 2. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 3. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 4. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248
• 5. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

Introduction to 3-(pyrrolidine-1-carbonyl)piperidine hydrochloride (CAS No. 937724-81-7) and Its Emerging Applications in Chemical Biology

3-(pyrrolidine-1-carbonyl)piperidine hydrochloride, identified by the chemical identifier CAS No. 937724-81-7, represents a significant compound in the realm of chemical biology and pharmaceutical research. This compound, featuring a unique structural motif combining a pyrrolidine and piperidine scaffold, has garnered attention due to its versatile applications in drug discovery and molecular pharmacology. The hydrochloride salt form enhances its solubility, making it particularly valuable for biochemical assays and medicinal chemistry investigations.

The structural framework of 3-(pyrrolidine-1-carbonyl)piperidine hydrochloride is characterized by a central carbonyl group bridging the pyrrolidine and piperidine rings. This configuration allows for diverse chemical modifications, enabling researchers to explore its potential as a precursor in synthesizing novel bioactive molecules. The compound’s dual functionality makes it an attractive candidate for developing small-molecule inhibitors targeting various biological pathways.

In recent years, advancements in computational chemistry and high-throughput screening have accelerated the discovery of pharmacophores with complex structures. 3-(pyrrolidine-1-carbonyl)piperidine hydrochloride has been employed in virtual screening campaigns to identify potential leads for therapeutic intervention. Its ability to interact with biological targets such as kinases and G-protein coupled receptors (GPCRs) has been particularly noteworthy. Preliminary studies suggest that derivatives of this compound exhibit promising activity in modulating signaling pathways associated with inflammation and neurodegeneration.

The compound’s relevance is further underscored by its incorporation into innovative drug design strategies. For instance, its scaffold has been utilized to develop peptidomimetics—molecules mimicking the structure and function of natural peptides but with enhanced stability and bioavailability. Such peptidomimetics are being explored for their potential in treating metabolic disorders and cancer, where precise modulation of protein-protein interactions is crucial.

Recent experimental investigations have highlighted the synthetic versatility of 3-(pyrrolidine-1-carbonyl)piperidine hydrochloride. Researchers have leveraged its reactive sites to introduce diverse substituents, creating libraries of analogs for structure-activity relationship (SAR) studies. These studies have provided insights into optimizing potency, selectivity, and pharmacokinetic properties. Notably, some derivatives have demonstrated inhibitory effects on enzymes implicated in viral replication, offering a potential avenue for antiviral drug development.

The hydrochloride salt form of this compound enhances its suitability for industrial-scale synthesis and formulation. Its improved solubility facilitates its use in liquid formulations, which is particularly advantageous for preclinical studies requiring rapid absorption and biodistribution. Additionally, the stability of the salt form under various storage conditions makes it a reliable reagent for collaborative research projects across academic institutions and pharmaceutical companies.

From a mechanistic standpoint, 3-(pyrrolidine-1-carbonyl)piperidine hydrochloride has been investigated for its role in modulating enzyme conformational dynamics. Its ability to bind to specific residues within target proteins can induce conformational changes that alter enzyme activity. This property has been exploited in developing allosteric inhibitors—compounds that bind to sites distinct from the enzyme’s active site but still elicit functional changes. Such inhibitors are often more selective and less susceptible to resistance mutations compared to traditional competitive inhibitors.

The compound’s potential extends beyond enzymatic targets; it has also shown promise in interactions with nucleic acids. Certain derivatives have been found to interfere with DNA replication or transcription by binding to non-specific regions of nucleic acids, thereby disrupting cellular processes essential for pathogen survival or cancer cell proliferation. These findings open new avenues for antiviral and anticancer therapies targeting nucleic acid metabolism.

Regulatory considerations play a crucial role in the development of compounds like 3-(pyrrolidine-1-carbonyl)piperidine hydrochloride. Given its complex structure, thorough characterization under Good Manufacturing Practices (GMP) conditions is essential for clinical trials and commercialization. Collaborative efforts between synthetic chemists, biochemists, and regulatory experts ensure that the compound meets stringent safety and efficacy standards before reaching preclinical or clinical evaluation stages.

The future prospects of 3-(pyrrolidine-1-carbonyl)piperidine hydrochloride are bright, with ongoing research exploring its role in precision medicine approaches. Personalized medicine relies on identifying biomarkers that predict individual responses to therapeutic agents, allowing for tailored treatment regimens. The compound’s modularity enables the creation of customized derivatives designed to interact specifically with biomarkers associated with genetic or environmental risk factors.

In conclusion, 3-(pyrrolidine-1-carbonyl)piperidine hydrochloride (CAS No. 937724-81-7) stands as a pivotal compound in modern chemical biology and pharmaceutical innovation. Its unique structural features, synthetic adaptability, and broad range of biological activities position it as a cornerstone in drug discovery efforts aimed at addressing complex diseases such as cancer, neurodegenerative disorders, and infectious diseases. As research methodologies continue to evolve, this compound will undoubtedly remain at the forefront of molecular pharmacology advancements.

• 1153767-88-4(2-methyl-2,9-diazaspiro[4.5]decan-1-one;hydrochloride)
• 35090-94-9(3-(pyrrolidine-1-carbonyl)piperidine)
• 937725-05-8(N,N-Dipropyl-3-piperidinecarboxamide hydrochloride)
• 1242336-75-9(2-methyl-3a,4,5,6,7,7a-hexahydro-1H-pyrrolo[3,4-c]pyridin-3-one)
• 1220039-05-3(1-(piperidine-3-carbonyl)azepane hydrochloride)
• 845885-83-8(3-(piperidine-1-carbonyl)piperidine hydrochloride)
• 845885-84-9(4-methyl-1-(piperidine-3-carbonyl)piperidine hydrochloride)
• 1220034-94-5((3-Methyl-1-piperidinyl)(3-piperidinyl)methanone hydrochloride)
• 917505-24-9(Piperidin-1-yl-pyrrolidin-3-yl-methanone hydrochloride)
• 1203797-13-0(7-methyl-2,7-diazaspiro4.5decan-6-one)